Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.verified

BLCM

Price:

$0.07475

Market Cap:

$778.33K

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an ...[Read more]

Industry

Biotechnology

IPO Date

2014-12-18

Stock Exchange

NASDAQ

Ticker

BLCM

The Enterprise Value as of December 2024 (TTM) for Bellicum Pharmaceuticals, Inc. (BLCM) is -5130674.00

According to Bellicum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -5130674.00. This represents a change of 40.30% compared to the average of -3656976.31 of the last 4 quarters.

Bellicum Pharmaceuticals, Inc. (BLCM) Historical Enterprise Value (quarterly & annually)

How has BLCM Enterprise Value performed in the past?

The mean historical Enterprise Value of Bellicum Pharmaceuticals, Inc. over the last ten years is 174.80M. The current -5130674.00 Enterprise Value has changed -393.52% with respect to the historical average. Over the past ten years (40 quarters), BLCM's Enterprise Value was at its highest in in the December 2014 quarter at 709.80M. The Enterprise Value was at its lowest in in the December 2021 quarter at -22744827.96.

Quarterly (TTM)
Annual

Average

174.80M

Median

167.03M

Minimum

-29014601.94

Maximum

463.94M

Bellicum Pharmaceuticals, Inc. (BLCM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bellicum Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.36%

Maximum Annual Enterprise Value = 463.94M

Minimum Annual Increase = -288.08%

Minimum Annual Enterprise Value = -29014601.94

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022359.34K-101.24%
2021-29014601.94107.36%
2020-13992638.73-288.08%
20197.44M-93.22%
2018109.74M-58.27%
2017262.99M-21.66%
2016335.72M-27.64%
2015463.94M20.05%
2014386.46M72.28%
2013224.32M-3.93%

Bellicum Pharmaceuticals, Inc. (BLCM) Average Enterprise Value

How has BLCM Enterprise Value performed in the past?

The current Enterprise Value of Bellicum Pharmaceuticals, Inc. (BLCM) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-14215967.61

5-year avg

14.91M

10-year avg

174.80M

Bellicum Pharmaceuticals, Inc. (BLCM) Enterprise Value vs. Peers

How is BLCM’s Enterprise Value compared to its peers?

Bellicum Pharmaceuticals, Inc.’s Enterprise Value is less than Cellectis S.A. (43.49M), less than Adaptimmune Therapeutics plc (55.99M), greater than Calithera Biosciences, Inc. (-23784513.00), less than Atara Biotherapeutics, Inc. (80.23M), less than Affimed N.V. (23.63M),

CompanyEnterprise ValueMarket cap
43.49M$112.47M
55.99M$148.11M
-23784513.00$487.00
80.23M$76.78M
23.63M$18.88M

Build a custom stock screener for Bellicum Pharmaceuticals, Inc. (BLCM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellicum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellicum Pharmaceuticals, Inc. (BLCM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellicum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bellicum Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the 3-year average Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the 5-year average Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM)?

How does the current Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM) compare to its historical average?